Mankind Pharma Q1FY25-26: Strong Volume Recovery Drives 25% Revenue Growth
Moneylife Digital Team 12 August 2025
Mankind Pharma Limited (Mankind) reported a strong operational comeback in Q1FY25-26, with revenues jumping 24% to Rs3,570 crore, marking the company's return to robust growth after a period of...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Get access to complete archives
Rs 5000 + GST
 
 
Already a subscriber ? Log in
Free Helpline
Legal Credit
Feedback